neurodegenerative-diseases

Study finds ADHD is associated with dementia

by

Multi­gen­er­a­tional Study Finds Links Between ADHD, Demen­tia Risk (Health Day):

Atten­tion-deficit/hy­per­ac­tiv­i­ty dis­or­der (ADHD) appears to be some­how linked to risk of demen­tia and Alzheimer’s dis­ease, a new multi­gen­er­a­tional study has found.

Par­ents and grand­par­ents of peo­ple with ADHD have a high­er risk of Alzheimer’s and demen­tia than peo­ple with no ADHD in their fam­i­ly, Swedish researchers said.

Specif­i­cal­ly, par­ents of an ADHD child have a 34% high­er risk of demen­tia and 55% high­er risk of Alzheimer’s, the results showed. Grand­par­ents have about an 11% increased risk of either con­di­tion. [Read more…] about Study finds ADHD is asso­ci­at­ed with dementia

Neurostimulation device GammaSense by Cognito Therapeutics secures FDA Breakthrough Device Designation to explore Alzheimer’s Disease applications

by

Cred­it: The Picow­er Insti­tute @ MIT

Cog­ni­to Ther­a­peu­tics nets FDA break­through label for light, sound ther­a­py for Alzheimer’s dis­ease (Fierce Biotech):

Using spe­cif­ic fre­quen­cies of flash­ing lights and sounds to stim­u­late the brain’s elec­tri­cal activ­i­ty, Cog­ni­to Ther­a­peu­tics believes it can help treat Alzheimer’s dis­ease by ener­giz­ing neu­rons and reac­ti­vat­ing the immune system.

[Read more…] about Neu­rostim­u­la­tion device Gam­maSense by Cog­ni­to Ther­a­peu­tics secures FDA Break­through Device Des­ig­na­tion to explore Alzheimer’s Dis­ease applications

September 17th @ UC Berkeley: Disrupting neurodegenerative diseases

by

__________

Quick heads-up about a great event next month for those based in the San Fran­cis­co Bay Area.

  • When: Tues­day, Sep­tem­ber 17, 2019 / 8:30 AM – 6:00 PM PDT
  • Where: Pauley Ball­room, UC Berkeley
  • What: 2019 UC Berke­ley Aging Research & Tech­nol­o­gy Sum­mit: Dis­rupt­ing Neu­rode­gen­er­a­tive Diseases

Alzheimer’s and neu­rode­gen­er­a­tive dis­eases are [Read more…] about Sep­tem­ber 17th @ UC Berke­ley: Dis­rupt­ing neu­rode­gen­er­a­tive diseases

The World Economic Forum hosts Global Future Council on Neurotechnologies in Dubai (November 10–12th)

by

Quick heads-up on a very promis­ing event.

Descrip­tion: Quick­ly devel­op­ing neu­rotech­nolo­gies will have an impact on entire indus­tries, gov­ern­ments, and soci­eties in the future. The Glob­al Future Coun­cil on Neu­rotech­nolo­gies will explore these tech­no­log­i­cal devel­op­ments and their eth­i­cal impli­ca­tions for soci­ety. [Read more…] about The World Eco­nom­ic Forum hosts Glob­al Future Coun­cil on Neu­rotech­nolo­gies in Dubai (Novem­ber 10–12th)

News: Advanced Brain Monitoring receives Global Health and Pharma Award for clinical-grade platforms monitoring brain’s electrical activity

by

—

Advanced Brain Mon­i­tor­ing Named “Most Inno­v­a­tive Med­ical Device Com­pa­ny” at Glob­al Health and Phar­ma Awards (Sleep Review):

“Advanced Brain Mon­i­tor­ing Inc was named the “Most Inno­v­a­tive Med­ical Device Com­pa­ny” by Glob­al Health and Phar­ma at its 2016 Health­care and Phar­ma­ceu­ti­cal awards. “This award rec­og­nizes our company’s suc­cess­es in devel­op­ing tech­nolo­gies which enable clin­i­cians and clin­i­cal tri­al spon­sors to pro­file brain health through the analy­sis of the brain’s elec­tri­cal activ­i­ty (EEG) dur­ing sleep and wake,” says Chris Berka, Advanced Brain Mon­i­tor­ing CEO…The com­pa­ny was recent­ly award­ed a $1.5 mm grant from Nation­al Insti­tute of Health to expand its data­base of awake and sleep EEG in patients with neu­rode­gen­er­a­tive dis­eases. “The envi­sioned future is for rou­tine brain health assess­ments dur­ing sleep and wak­ing to be con­duct­ed in a man­ner sim­i­lar to a mam­mo­gram or colonoscopy,” says Berka. “Ulti­mate­ly, ear­ly detec­tion will increase the like­li­hood that an inter­ven­tion can be matched to the patient based on the pres­ence of brain bio­mark­ers and admin­is­tered pri­or to the onset of cog­ni­tive decline.”

To learn more:

Lessons from the SharpBrains Summit: Status Quo Not an Option

by

The 2011 Sharp­Brains Sum­mit gath­ered  more than 260 research and indus­try lead­ers in 16 coun­tries for 3 days to dis­cuss the chang­ing land­scape. Held online, par­tic­i­pants from all over the globe  attend­ed to hear more than 40 thought lead­ers, sci­en­tists, entre­pre­neurs and pol­i­cy mak­ers out­line the evolv­ing mar­ket­place. Dis­cus­sion moved from cog­ni­tive fit­ness to neu­ro­plas­tic­i­ty, across reg­u­la­to­ry and pol­i­cy trends, and new prod­uct launch­es by new and estab­lished play­ers  What did we take home from the Sharp­Brains Sum­mit? Was it nov­el con­sumer insights aris­ing from a new retail land­scape? What of pol­i­cy ini­tia­tives from inno­va­tion clus­ters around the globe? Do you see a future pop­u­lat­ed by neu­ro­science toolk­its, dri­ven by the inex­orable demo­graph­ic changes set to occur in the com­ing decades? Or was it a look “under the hood” of tech­nol­o­gy plat­forms devel­oped by cat­e­go­ry lead­ers that sharp­ened our insight? Here are 10 emerg­ing themes:

1. The Need for Stan­dard­iza­tion of methodologies 

A pro­fu­sion of cog­ni­tive and emo­tion­al health tests, bat­ter­ies and new tech­nolo­gies are crowd­ing the research envi­ron­ment. The NIH tool­box for the assess­ment of a broad range of cog­ni­tive domains [Read more…] about Lessons from the Sharp­Brains Sum­mit: Sta­tus Quo Not an Option